274 related articles for article (PubMed ID: 17928570)
21. Crucial role of neutrophils in the development of mechanical inflammatory hypernociception.
Cunha TM; Verri WA; Schivo IR; Napimoga MH; Parada CA; Poole S; Teixeira MM; Ferreira SH; Cunha FQ
J Leukoc Biol; 2008 Apr; 83(4):824-32. PubMed ID: 18203872
[TBL] [Abstract][Full Text] [Related]
22. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors.
Kim EH; Surh YJ
Biochem Pharmacol; 2006 Nov; 72(11):1516-28. PubMed ID: 16987499
[TBL] [Abstract][Full Text] [Related]
23. 15-deoxy-Delta12,14-prostaglandin J2-induced down-regulation of endothelial nitric oxide synthase in association with HSP70 induction.
Hwang J; Lee HI; Chang YS; Lee SJ; Kim KP; Park SI
Biochem Biophys Res Commun; 2007 May; 357(1):206-11. PubMed ID: 17418102
[TBL] [Abstract][Full Text] [Related]
24. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.
Emi M; Maeyama K
Biochem Pharmacol; 2004 Apr; 67(7):1259-67. PubMed ID: 15013841
[TBL] [Abstract][Full Text] [Related]
25. delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway.
Pacheco DF; Reis GM; Francischi JN; Castro MS; Perez AC; Duarte ID
Life Sci; 2005 Nov; 78(1):54-60. PubMed ID: 16135369
[TBL] [Abstract][Full Text] [Related]
26. Involvement of nitric oxide in the inhibition of bone cancer-induced hyperalgesia through the activation of peripheral opioid receptors in mice.
Menéndez L; Juárez L; García V; Hidalgo A; Baamonde A
Neuropharmacology; 2007 Jul; 53(1):71-80. PubMed ID: 17543351
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells.
Sabichi AL; Subbarayan V; Llansa N; Lippman SM; Menter DG
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1704-9. PubMed ID: 15533896
[TBL] [Abstract][Full Text] [Related]
28. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the mechanism underlying the peripheral antinociceptive action of sildenafil in the formalin test.
Ambriz-Tututi M; Velázquez-Zamora DA; Urquiza-Marín H; Granados-Soto V
Eur J Pharmacol; 2005 Apr; 512(2-3):121-7. PubMed ID: 15840396
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages.
Kim HY; Kim HS
Immunol Cell Biol; 2007 Jan; 85(1):60-7. PubMed ID: 17130903
[TBL] [Abstract][Full Text] [Related]
31. Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats.
Araiza-Saldaña CI; Reyes-García G; Bermúdez-Ocaña DY; Pérez-Severiano F; Granados-Soto V
Eur J Pharmacol; 2005 Dec; 527(1-3):60-70. PubMed ID: 16305795
[TBL] [Abstract][Full Text] [Related]
32. Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism.
Olmos G; Conde I; Arenas I; Del Peso L; Castellanos C; Landazuri MO; Lucio-Cazana J
Cell Signal; 2007 Oct; 19(10):2098-105. PubMed ID: 17658243
[TBL] [Abstract][Full Text] [Related]
33. 15d-PGJ2: the anti-inflammatory prostaglandin?
Scher JU; Pillinger MH
Clin Immunol; 2005 Feb; 114(2):100-9. PubMed ID: 15639643
[TBL] [Abstract][Full Text] [Related]
34. 15-deoxy prostaglandin J2 enhances allyl alcohol-induced toxicity in rat hepatocytes.
Maddox JF; Domzalski AC; Roth RA; Ganey PE
Toxicol Sci; 2004 Feb; 77(2):290-8. PubMed ID: 14657518
[TBL] [Abstract][Full Text] [Related]
35. An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Delta 12,14-prostaglandin J2 on proteasome.
Shibata T; Yamada T; Kondo M; Tanahashi N; Tanaka K; Nakamura H; Masutani H; Yodoi J; Uchida K
Biochemistry; 2003 Dec; 42(47):13960-8. PubMed ID: 14636064
[TBL] [Abstract][Full Text] [Related]
36. Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages.
Janabi N
J Immunol; 2002 May; 168(9):4747-55. PubMed ID: 11971025
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of LPS-induced chemokine KC expression by 15-deoxy-delta12,14-prostaglandin J2 in mouse peritoneal macrophages.
Kim HY; Kim HK; Kim JR; Kim HS
Immunol Cell Biol; 2005 Jun; 83(3):286-93. PubMed ID: 15877607
[TBL] [Abstract][Full Text] [Related]
38. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.
Zhang M; Deng C; Zheng J; Xia J; Sheng D
Int Immunopharmacol; 2006 Aug; 6(8):1233-42. PubMed ID: 16782535
[TBL] [Abstract][Full Text] [Related]
39. ERK-1/-2 and p38 kinase oppositely regulate 15-deoxy-delta(12,14)-prostaglandinJ(2)-Induced PPAR-gamma activation that mediates dedifferentiation but not cyclooxygenase-2 expression in articular chondrocytes.
Yoon EK; Lee WK; Lee JH; Yu SM; Hwang SG; Kim SJ
J Korean Med Sci; 2007 Dec; 22(6):1015-21. PubMed ID: 18162716
[TBL] [Abstract][Full Text] [Related]
40. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells.
Subbarayan V; Sabichi AL; Kim J; Llansa N; Logothetis CJ; Lippman SM; Menter DG
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1710-6. PubMed ID: 15533897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
